Opaleye Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

Opaleye Management’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-335,000	Closed	-$4.56M	–	44
2014 Q4	$4.56M	Sell	335,000 -215,000	-39%	-$2.4M	2.3%	14
2014 Q3	$4.93M	Buy	550,000 +50,000	+10%	+$538K	3.85%	8
2014 Q2	$6.76M	Buy	500,000 +65,000	+15%	+$678K	5.83%	5
2014 Q1	$4.32M	Buy	+435,000	New	+$5.41M	3.19%	10

Other funds holding GNMK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Opaleye Management's GNMK Position: Q1 2015 in Review

Opaleye Management sold out of GenMark Diagnostics, Inc (GNMK) in Q1 2015, closing a stake of 335,000 shares — an estimated $4.56M sold.

Opaleye Management first reported a position in GNMK in Q1 2014 and held it in 4 quarters. The position peaked at $6.76M in Q2 2014. 80 funds tracked by Wall St. Rank hold GNMK as of Q1 2015.

Opaleye Management reported no remaining GenMark Diagnostics, Inc position as of Q1 2015 after selling out during the quarter.
Opaleye Management sold 335,000 GenMark Diagnostics, Inc shares in Q1 2015, an estimated $4.56M.
Opaleye Management first reported a position in GenMark Diagnostics, Inc in Q1 2014 and held it in 4 quarters.
Opaleye Management's GenMark Diagnostics, Inc position peaked at $6.76M in Q2 2014.
80 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2015.

Based on Opaleye Management's 13F filing for Q1 2015, filed 15 May 2015.